Dianeal PD1
FDA Approves Procysbi for Rare Genetic Condition »
"The U.S. Food and Drug Administration today approved Procysbi (cysteamine bitartrate) for the management of nephropathic cystinosis in children and adults. Procysbi was granted orphan product designation because it is intended to treat a rare dis"...
Read the FDA Approves Procysbi for Rare Genetic Condition article »
Dianeal PD-1
DIANEAL PD-1
(peritoneal) Dialysis Solution
AMBU-FLEX III Container
For Peritoneal Dialysis For intraperitoneal administration only
DRUG DESCRIPTION
DIANEAL PD-1 peritoneal dialysis solutions in AMBU-FLEX lll containers with a flanged port are sterile, nonpyrogenic solutions for intraperitoneal administration only. They contain no bacteriostatic or antimicrobial agents or added buffers.
Composition, calculated osmolarity, pH and ionic concentrations are shown in Table 1.
Potassium is omitted from DIANEAL solutions because dialysis may be performed to correct hyperkalemia. In situations in which there is a normal serum potassium level or hypokalemia, the addition of potassium chloride (up to a concentration of 4 mEq/L) may be indicated to prevent severe hypokalemia. Addition of potassium chloride should be made after careful evaluation of serum and total body potassium and only under the direction of a physician. Frequent monitoring of serum electrolytes is indicated.
The osmolarities shown in Table 1 are calculated values. As an example, measured osmolarity by freezing point depression determination of DIANEAL PD-1 peritoneal dialysis solution with 1.5% dextrose is approximately 334 mOsmol/L, compared with measured values in normal human serum of 280 mOsmol/L.
The plastic container is fabricated from a specially formulated polyvinyl chloride (PL 146 Plastic). The amount of water that can permeate from inside the container into the overwrap is insufficient to affect the solution significantly. Solutions in contact with the plastic container can leach out certain of its chemical components in very small amounts within the expiration period, e.g., di-2-ethylhexyl phthalate (DEHP), up to 5 parts per million; however, the safety of the plastic has been confirmed in tests in animals according to USP biological tests for plastic containers as well as by tissue culture toxicity studies.
Table 1
| Composition/100 mL | Osmolarity (mOsmol/L) (calc) |
pH | Ionic Concentration (mEq/L) |
How Supplied | ||||||||||||
| *Dextrose, Hydrous, USP | Sodium Chloride, USP (NaCl) | Sodium Lactate (C3H5NaO3) |
Calcium Chloride, USP (CaCl2·2H2O) |
Magnesium Chloride, USP MgCl2·6H2O) |
Sodium | Calcium | Magnesium | Chloride | Lactate | Fill Volume (mL) |
Container Size (mL) |
Code | NDC | |||
| DIANEAL PD-1 Peritoneal Dialysis Solution with 1.5% Dextrose |
1.5 g | 567 mg |
392 mg | 25.7 mg | 15.2 mg | 347 | 5.2 (4.0 to 6.5) | 132 | 3.5 | 1.5 | 102 | 35 | 2000 5000 | 2000 5000 | 5B5136 5B5190 |
NDC 0941-0377-46 NDC 0941-0377-25 |
| DIANEAL PD-1 Peritoneal Dialysis Solution with 2.5% Dextrose |
2.5 g |
567 mg |
392 mg |
25.7 mg |
15.2 mg |
398 | 5.2 (4.0 to 6.5) |
132 | 3.5 | 1.5 | 102 | 35 | 2000 2000 5000 |
2000 3000 5000 |
5B5146 5B5147 5B5191 |
NDC 0941-0383-46 NDC 0941-0383-47 NDC 0941-0383-25 |
| DIANEAL PD-1 Peritoneal Dialysis Solution with 4.25% Dextrose |
4.25 | 567 mg | 392 mg |
25.7 mg |
15.2 mg |
486 | 5.2 (4.0 to 6.5) |
132 | 3.5 | 1.5 | 102 | 35 | 2000 5000 |
3000 5000 |
5B5157 5B5192 |
NDC 0941-0379-47 NDC 0941-0379-25 |
|
Last reviewed on RxList: 12/25/2005
This monograph has been modified to include the generic and brand name in many instances.
Additional Dianeal PD-1 Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Women's Health
Find out what women really need.






